These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34595167)

  • 1. Characterization of Molecular Subtypes in Head and Neck Squamous Cell Carcinoma With Distinct Prognosis and Treatment Responsiveness.
    Zhang P; Li S; Zhang T; Cui F; Shi JH; Zhao F; Sheng X
    Front Cell Dev Biol; 2021; 9():711348. PubMed ID: 34595167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three distinct genomic subtypes of head and neck squamous cell carcinoma associated with clinical outcomes.
    Lee DJ; Eun YG; Rho YS; Kim EH; Yim SY; Kang SH; Sohn BH; Kwon GH; Lee JS
    Oral Oncol; 2018 Oct; 85():44-51. PubMed ID: 30220319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
    Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of tumor antigens and immune subtypes in head and neck squamous cell carcinoma for mRNA vaccine development.
    Chen Y; Jiang N; Chen M; Sui B; Liu X
    Front Cell Dev Biol; 2022; 10():1064754. PubMed ID: 36467412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL family-related classification predicts prognosis and response to immunotherapy in patients with head and neck squamous cell carcinoma based on TCGA and GEO databases.
    Gao S; Tang X; Gao C; Gao X; Guo X; Luo Y; Li S; Gong G; Zhang Y; Lin S
    Transl Cancer Res; 2024 Feb; 13(2):999-1015. PubMed ID: 38482440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 7. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma.
    Wang Z; Yuan H; Huang J; Hu D; Qin X; Sun C; Chen G; Wang B
    Head Neck; 2021 Jan; 43(1):182-197. PubMed ID: 33009692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis.
    Chen X; Yan B; Lou H; Shen Z; Tong F; Zhai A; Wei L; Zhang F
    Mol Immunol; 2018 Apr; 96():28-36. PubMed ID: 29477933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism-associated molecular classification and prognosis signature of head and neck squamous cell carcinoma.
    Jiang M; Gu X; Xu Y; Wang J
    Heliyon; 2024 Mar; 10(6):e27587. PubMed ID: 38501009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
    Song D; Tian J; Han X; Li X
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.
    Shen Y; Liu J; Zhang L; Dong S; Zhang J; Liu Y; Zhou H; Dong W
    Biomed Res Int; 2019; 2019():7376034. PubMed ID: 31485443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma.
    Katsoulakis E; Yu Y; Apte AP; Leeman JE; Katabi N; Morris L; Deasy JO; Chan TA; Lee NY; Riaz N; Hatzoglou V; Oh JH
    Oral Oncol; 2020 Nov; 110():104877. PubMed ID: 32619927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune-related lncRNA classification of head and neck squamous cell carcinoma.
    Cao R; Cui L; Zhang J; Ren X; Cheng B; Xia J
    Cancer Cell Int; 2022 Jan; 22(1):25. PubMed ID: 35033066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma.
    Cao B; Wang Q; Zhang H; Zhu G; Lang J
    Oncoimmunology; 2018; 7(2):e1392427. PubMed ID: 29308323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a m
    Zhao X; Cui L
    Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis-related molecular subtyping in head and neck squamous cell carcinoma patients based on glycolytic/cholesterogenic gene data.
    Zhou Z; Tang J; Lu Y; Jia J; Luo T; Su K; Dai X; Zhang H; Liu O
    Cancer Cell Int; 2023 Feb; 23(1):37. PubMed ID: 36841765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study.
    Zhang L; Li B; Peng Y; Wu F; Li Q; Lin Z; Xie S; Xiao L; Lin X; Ou Z; Cai T; Rong H; Fan S; Li J
    Oral Oncol; 2020 Nov; 110():104943. PubMed ID: 32919362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
    Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
    Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma.
    Long J; Zhang S; Zeng X; Ouyang Y; Wang Y; Hu Z; Ye Y; Wu W; Jin F; Zhou S; Zeng Z
    Front Mol Biosci; 2020; 7():586344. PubMed ID: 33330624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.